Immunisation against chlamydia trachomatis

Details Immunisation against chlamydia trachomatis Immunisation against chlamydia trachomatis

2008-03-06

2010-11-30

Mondesi, Robert B (Department: 1645)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Amino acid sequence disclosed in whole or in part; or...

Reexamination Certificate

active

07842297

ABSTRACT:
The present invention provides antigenic proteins ofChlamydia trachomatis. The proteins of the present invention are useful for eliciting an immune response toChlamydiain a patient. For example, an effective amount of protein of the present invention or fraction thereof may be administered to a patient for eliciting aChlamydiaspecific immune response. In another example, a method of raising an antibody specific forChlamydia trachomatiselementary bodies (EB) is provided in which a protein of the present invention is administered to a patient.

REFERENCES:
patent: 7041490 (2006-05-01), Griffais et al.
patent: 2002/0061848 (2002-05-01), Bhatia et al.
patent: WO 95/12411 (1995-05-01), None
patent: WO 99/27105 (1999-06-01), None
patent: WO 99/28475 (1999-06-01), None
patent: WO 00/27994 (2000-05-01), None
patent: WO 00/34483 (2000-06-01), None
patent: WO 01/40474 (2001-06-01), None
patent: WO 01/81379 (2001-11-01), None
patent: WO 02/08267 (2002-01-01), None
patent: WO 03/041560 (2003-05-01), None
Stephens RS et al: Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis 'see comments!)Science, American Association for the Advancement of Science., US, vol. 282, No. 5389, Oct. 23, 1998, pp. 754-759, XP002104802 issn: 0036-8075.
Database EMBL ′Online! Oct. 16, 2001, XP002258111 accession No. EBI Database accession No. 084879 * 100% identity over the whole length with SEQ DI No. 1*.
Kalman et al., “Comparative Genomes of Chlamydia pneumoniae and C. trachomatis,” Nature Genetics, 21(4), 1999, pp. 385-389.
Anonymous Third party observations filed under Article 115 EPC for European Patent Applications 99939279.8; 99939280.6; 99951023.3; 99954126.1; 99958455.0; 99960752.6; 99963037.9; 00901235.2; 00908862.6; 00925004.4; 00962125.1; 00962134.3; 00984741.9; 01928775.4; 01931274.3; 01954278.6; and 01959114.8, dated Mar. 23, 2006.
Greenspan et al. Nature Biotechnology 7: 936-937,1999.
Bowie et al., Science, 1990, 247:1306-1310.
Freshney, Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, p. 4.
Dermer, Bio/Technology, 1994, vol. 12, p. 320.
STIC search report, p. 4, Feb. 2006.
Clifton, D.R. et al: “A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin,” PNAS, Jul. 6, 2004, vol. 101,No. 27, pp. 10166-10171.
Silk, Excerpt from On the Shores of the Unknown, A Short History of the Universe, Cambridge University Press, paged 1-10.
Colman, Res. Immunol. 145: 33-36, 1994.
Score Sequence Alignment, result 2.

Affiliated with

Also associated with

Rating

Immunisation against chlamydia trachomatis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunisation against chlamydia trachomatis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunisation against chlamydia trachomatis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4172949